GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OTCPK:ZLDPF) » Definitions » Price-to-Tangible-Book

Zealand Pharma A/S (Zealand Pharma A/S) Price-to-Tangible-Book : 22.13 (As of May. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Zealand Pharma A/S Price-to-Tangible-Book?

As of today (2024-05-01), Zealand Pharma A/S's share price is $87.66. Zealand Pharma A/S's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $3.96. Hence, Zealand Pharma A/S's Price to Tangible Book Ratio of today is 22.13.

The historical rank and industry rank for Zealand Pharma A/S's Price-to-Tangible-Book or its related term are showing as below:

ZLDPF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.27   Med: 7.46   Max: 23.38
Current: 22.36

During the past 13 years, Zealand Pharma A/S's highest Price to Tangible Book Ratio was 23.38. The lowest was 2.27. And the median was 7.46.

ZLDPF's Price-to-Tangible-Book is ranked worse than
96.15% of 1221 companies
in the Biotechnology industry
Industry Median: 2.69 vs ZLDPF: 22.36

A closely related ratio is called PB Ratio. As of today, Zealand Pharma A/S's share price is $87.66. Zealand Pharma A/S's Book Value per Sharefor the quarter that ended in Dec. 2023 was $3.99. Hence, Zealand Pharma A/S's P/B Ratio of today is 21.96.


Zealand Pharma A/S Price-to-Tangible-Book Historical Data

The historical data trend for Zealand Pharma A/S's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S Price-to-Tangible-Book Chart

Zealand Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.12 7.47 7.17 12.49 14.05

Zealand Pharma A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.49 18.65 8.01 9.79 14.05

Competitive Comparison of Zealand Pharma A/S's Price-to-Tangible-Book

For the Biotechnology subindustry, Zealand Pharma A/S's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma A/S's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma A/S's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Zealand Pharma A/S's Price-to-Tangible-Book falls into.



Zealand Pharma A/S Price-to-Tangible-Book Calculation

Zealand Pharma A/S's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=87.66/3.961
=22.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Zealand Pharma A/S Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma A/S (Zealand Pharma A/S) Business Description

Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.